Michael M Abecassis Pharma Cyte Biotech, Inc. (PMCB) insider trading activity

PMCB Quotes by TradingView

Michael M Abecassis is Director of PharmaCyte Biotech, Inc.. Currently has a direct ownership of 22,292 shares of PMCB, which is worth approximately $17,610. The most recent transaction as insider was on Dec 12, 2025, when has been sold 16,875 shares (Common Stock) at a price of $1.02 per share, resulting in proceeds of $17,212. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.3K
n/a 3M change
n/a 12M change
Total Value Held $17,610

Michael M Abecassis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 12 2025
SELL
Payment of exercise price or tax liability
$17,212 $1.02 p/Share
16,875 Reduced 43.08%
22,292 Common Stock
Dec 12 2025
BUY
Grant, award, or other acquisition
-
37,500 Added 48.91%
39,167 Common Stock
MMA

Michael M Abecassis

Director
Las Vegas, NV

Track Institutional and Insider Activities on PMCB

Follow PharmaCyte Biotech, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PMCB shares.

Notify only if

Insider Trading

Get notified when an Pharma Cyte Biotech, Inc. insider buys or sells PMCB shares.

Notify only if

News

Receive news related to PharmaCyte Biotech, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PMCB